This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. slid 3.0% to $6.45 on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index remaining mostly unchanged at 17,928.92 and the Dow Jones Industrial Average falling 0.3% to 41,249.38.
Corbus Pharmaceuticals Holdings Inc. closed 89.6% below its 52-week high of $61.90, which the company reached on July 31st.
The stock demonstrated a mixed performance when compared to some of its competitors, as Vanda Pharmaceuticals Inc. fell 6.4% to $3.95, Fortress Biotech Inc. remained unchanged, and Viking Therapeutics Inc. fell 1.08% to $27.55.
Trading volume totaled 126,292, compared to the 50-day average of 192,141.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 09, 2025 16:35 ET (20:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.